Genovac Antibody Discovery
UEI: XLZUCKG5TEJ5
• CAGE: 8TQ91
Overview
Awardee Type
Parent
(1 child)
Company Description
Genovac supports clients in biotech, pharma, and research with multi-species immunization for antibody discovery, advanced recovery technologies, characterization, and production.
Name
Genovac Antibody Discovery
Website
Headquarters
Fargo, ND
United States
United States
Most Recent Award
Sept. 6, 2024
Calculating
Federal contract recipient
GENOVAC ANTIBODY DISCOVERY LLC
(UEI XLZUCKG5TEJ5, CAGE 8TQ91)
is headquartered in Fargo ND.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The partnership
was founded in September 2020 and
federally registered in
December 2020.
Federal Award Analysis
Genovac Antibody Discovery federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
GENOVAC ANTIBODY DISCOVERY LLC
UEI
XLZUCKG5TEJ5
CAGE Code
8TQ91
Primary NAICS
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Partnership or Limited Liability Partnership
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Sept. 10, 2020
Initial Registration
Dec. 11, 2020
Last Registration
Oct. 7, 2024
Registration Activation
Oct. 7, 2024
Registration Expiration
Oct. 3, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
ND
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No